WordNet

write by means of a keyboard with types; "type the acceptance letter, please" (同)typewrite
a small metal block bearing a raised character on one end; produces a printed character when inked and pressed on paper; "he dropped a case of type, so they made him pick them up"
(biology) the taxonomic group whose characteristics are used to define the next higher taxon
a subdivision of a particular kind of thing; "what type of sculpture do you prefer?"
all of the tokens of the same symbol; "the word `element contains five different types of character"
printed characters; "small type is hard to read"
identify as belonging to a certain type; "Such people can practically be typed" (同)typecast
a soft thin (usually translucent) paper (同)tissue_paper
part of an organism consisting of an aggregate of cells having a similar structure and function
of or relating to recombinant DNA
a cell or organism in which genetic recombination has occurred
(biology) any agency bringing about activation; a molecule that increases the activity of an enzyme or a protein that increases the production of a gene product in DNA transcription
an inactive form of plasmin that occurs in plasma and is converted to plasmin by organic solvents

PrepTutorEJDIC

〈C〉(…の)『型』,タイプ,類型,種類(kind)《+of+名》 / 〈C〉(その種類の特質を最もよく表している)『典型』,手本,模範《+of+名》 / 〈U〉《集合的に》活字;〈C〉(1個の)活字 / 〈U〉(印刷された)字体,活字 / 〈C〉(貨幣・メダルなどの)模様,図柄 / 〈C〉血液型(blood group) / …‘を'タイプに打つ / (…として)…‘を'分類する《+名+as+名(doing)》 / …‘の'型を決める / タイプライターを打つ
〈U〉〈C〉(生物体の)『組織』 / 〈U〉〈C〉『薄織物』 / 〈U〉〈C〉水を吸収する柔らかな薄紙 / 〈C〉カーボンコピー用薄紙 / 〈C〉《a ~》(…を)織り交ぜて作ったもの《+of+名》 / =tissue paper
遺伝子の新結合による

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 急性虚血性脳卒中に対する再灌流療法 reperfusion therapy for acute ischemic stroke
2. ST上昇型心筋梗塞における血栓溶解療法の特性および臨床試験 characteristics of fibrinolytic thrombolytic agents and clinical trials in acute st elevation myocardial infarction
3. 幼児および小児における静脈血栓症および血栓塞栓症の診断および治療 diagnosis and treatment of venous thrombosis and thromboembolism in infants and children
4. 急性虚血性脳卒中における経静脈的線維素溶解（血栓溶解）治療：治療的使用 intravenous fibrinolytic thrombolytic therapy in acute ischemic stroke therapeutic use
5. ST上昇型心筋梗塞における血栓溶解療法の失敗または切迫再梗塞のマネージメント management of failed fibrinolysis thrombolysis or threatened reocclusion in acute st elevation myocardial infarction

Tissue Plasminogen Activator Binding to Superparamagnetic Iron Oxide Nanoparticle-Covalent Versus Adsorptive Approach.

Friedrich RP1, Zaloga J1, Schreiber E1, Tóth IY2, Tombácz E2, Lyer S1, Alexiou C3.
Nanoscale research letters.Nanoscale Res Lett.2016 Dec;11(1):297. doi: 10.1186/s11671-016-1521-7. Epub 2016 Jun 14.
Functionalized superparamagnetic iron oxide nanoparticles are frequently used to develop vehicles for drug delivery, hyperthermia, and photodynamic therapy and as tools used for magnetic separation and purification of proteins or for biomolecular imaging. Depending on the application, there are vari
PMID 27299652

Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?

Lee SH1, Kim BJ2, Han MK2, Park TH3, Lee KB4, Lee BC5, Yu KH5, Oh MS5, Cha JK6, Kim DH6, Nah HW6, Lee J7, Lee SJ8, Ko Y8, Kim JG8, Park JM9, Kang K9, Cho YJ10, Hong KS10, Choi JC11, Kim JT12, Choi K12, Kim DE13, Ryu WS13, Kim WJ14, Shin DI15, Yeo M15, Lee J16, Lee JS17, Gorelick PB18, Bae HJ19.
International journal of stroke : official journal of the International Stroke Society.Int J Stroke.2016 Oct;11(7):783-90. doi: 10.1177/1747493016654289. Epub 2016 Jun 16.
BACKGROUND: Current guidelines have contraindicated history of intracerebral hemorrhage for intravenous recombinant tissue plasminogen activator.AIM: This study aimed to investigate the safety and effectiveness of intravenous recombinant tissue plasminogen activator for patients who had previous int
PMID 27312681

A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.

Gong L1,2, Proulle V3, Fang C3, Hong Z1, Lin Z1, Liu M1,2, Xue G1, Yuan C1, Lin L3, Furie B3, Flaumenhaft R3, Andreasen P4, Furie B3, Huang M5,6,7.
Journal of cellular and molecular medicine.J Cell Mol Med.2016 Oct;20(10):1851-60. doi: 10.1111/jcmm.12875. Epub 2016 May 20.
Fibrinolysis is a process responsible for the dissolution of formed thrombi to re-establish blood flow after thrombus formation. Plasminogen activator inhibitor-1 (PAI-1) inhibits urokinase-type and tissue-type plasminogen activator (uPA and tPA) and is the major negative regulator of fibrinolysis.
PMID 27197780